Monte Carlo dose calculations will potentially reduce systematic errors that may be present in currently used dose calculation algorithms. However, Monte Carlo calculations inherently contain random errors, or statistical uncertainty, the level of which decreases inversely with the square root of computation time. Our purpose in this study was to determine the level of uncertainty at which a lung treatment plan is clinically acceptable. The evaluation methods to decide acceptability were visual examination of both isodose lines on CT scans and dose volume histograms ͑DVHs͒, and reviewing calculated biological indices. To study the effect of systematic and/or random errors on treatment plan evaluation, a simulated ''error-free'' reference plan was used as a benchmark. The relationship between Monte Carlo statistical uncertainty and dose was found to be approximately proportional to ͱdose. Random and systematic errors were applied to a calculated lung plan, creating dose distributions with statistical uncertainties of between 0% and 16% ͑1 s.d.͒ at the maximum dose point and also distributions with systematic errors of Ϫ16% to 16% at the maximum dose point. Critical structure DVHs and biological indices are less sensitive to calculation uncertainty than those of the target. Systematic errors affect plan evaluation accuracy significantly more than random errors, suggesting that Monte Carlo dose calculation will improve outcomes in radiotherapy. A statistical uncertainty of 2% or less does not significantly affect isodose lines, DVHs, or biological indices.
I. INTRODUCTION
The era of routine clinical Monte Carlo treatment planning for radiotherapy is imminent. Monte Carlo calculations are potentially more accurate than the best currently available commercial algorithms. However, with the advent of Monte Carlo treatment planning, some new challenges need to be addressed. One such challenge is how to deal with the statistical uncertainty inherent in all Monte Carlo calculations.
With a Monte Carlo calculation, increased accuracy ͑re-duced systematic error͒ is traded at the cost of statistical uncertainty ͑random error͒. Due to the need to make assumptions about the distribution of the electrons above the target, imperfections in beam alignment, blemishes in the treatment head manufacture, etc., along with treatment setup errors and patient organ motion, Monte Carlo ͑even ignoring limitations in the modeled physics͒ is not perfectly accurate in computing dose.
The variance of a Monte Carlo calculation result decreases inversely to the computer time used to solve the problem. 1 Hence the statistical uncertainty decreases with the square root of calculation time, which converges slowly. Obviously calculations with no uncertainty are most desirable, however, this would take infinite time to calculate. For a Monte Carlo dose calculation, we must accept a certain level of statistical fluctuations.
Our aim in this research was first to determine the characteristics of Monte Carlo dose calculation uncertainty and, second, to use these characteristics to establish which statistical uncertainty level is acceptable for radiotherapy dose evaluation.
II. METHOD AND MATERIALS

A. Determining the characteristics of Monte Carlo uncertainty
Monte Carlo calculations were performed to determine the properties of the statistical fluctuations as a function of the dose level in a Monte Carlo generated dose distribution. These calculations used EGS4 2 /BEAM 3 for the phase space creation and MCVRTP ͓MCVRTP is a Cϩϩ Monte Carlo code provided by ADAC Laboratories ͑ADAC Laboratories, Milpitas, CA 95035͒ that uses many of the published algorithms of EGS4͔ for the patient dose calculation. This configuration was used to obtain a dose distribution for a 10ϫ10 cm 2 open, and 20ϫ20 cm 2 45°wedged 6 MV field at 100 cm SSD incident on a water phantom of size 40ϫ40ϫ40 cm 3 divided into 0.4ϫ1ϫ0.5 cm 3 voxels. Here 2ϫ10 8 particles were sampled from a BEAM-generated phase space file for a Varian ͑Varian Oncology Systems, Palo Alto, CA 94304͒ 2100 C in 6 MV mode stored at the monitor chamber exit ͑containing 7ϫ10 7 particles stored with cylindrical symmetry͒, and each particle incident on the patient was reused 17 times. The discrete electron ͑AE͒ and photon ͑AP͒ particle creation thresholds, and electron ͑ECUT͒ and photon ͑PCUT͒ transport thresholds were AEϭECUTϭ0.7 MeV, APϭPCUTϭ0.01 MeV.
The variance ͓note that variance in this work refers to the square of the standard error of the mean, ( x ) 2 ͔ was calculated by considering the energy deposition in each voxel of each individual particle history as a separate sample, which minimizes the dispersion of the variance.
It was hypothesized that the variance for a Monte Carlo calculation is proportional to the dose ͑see the results for justification of this hypothesis͒. This hypothesis assumes that the electron energy spectrum varies little throughout the phantom. To investigate the validity of this hypothesis statistical uncertainty was applied to a ''random error-free'' 10ϫ10 cm 2 6 MV dose distribution, calculated with convolution. To add statistical uncertainty to a dose distribution, the uncertainty in the maximum dose is specified, D max . For each voxel i, the simulated dose D i is calculated by sampling a Gaussian distribution centered on 0, (G()), whose variance is proportional to dose, and adding the sampled value to the original dose,
͑1͒
To check the implementation of the variance/dose approximation, fields with added statistical uncertainty were compared to actual Monte Carlo calculated distributions. The uncertainties ͑1 ͒ in the maximum dose point were 0.6, 4.0, and 14.0%.
B. Determining the uncertainty level acceptable for radiotherapy plan evaluation
A five-field radiotherapy plan to treat a lung tumor was used to assess the effect of Monte Carlo uncertainty on plan evaluation. The evaluation methods investigated were isodose curves, dose volume histograms ͑DVHs͒, tumor control probability ͑TCP͒, and normal tissue complication probability ͑NTCP͒. The CT information, contours, beams, and beam weights used here were those used for the patient's treatment. A lung case was chosen, as plans with large density and/or atomic number variations are those for which Monte Carlo calculations will likely be most useful.
Monte Carlo results without random errors are not possible ͑the calculation would take infinite time͒, however, a reference plan with no statistical uncertainty was needed, as the benchmark with which to compare plans with added random or systematic errors. Hence, the reference plan was calculated using the best available random error-free algorithm in our department, the Pinnacle 3 ͑ADAC Laboratories, Milpitas, CA 95035͒ collapsed cone convolution algorithm. Discrepancies between a convolution calculated plan and a Monte Carlo calculated plan are not important here, as relative dose differences as a function of added uncertainty are being investigated. Statistical uncertainty was added in the same manner as that described above for the 10ϫ10 cm 2 field incident on a water phantom. Statistical uncertainty levels simulated were 0%, 0.5%, 1%, 2%, 4%, 8%, and 16% of the maximum dose for each beam. The voxel size used for the calculation was 3.0ϫ3.0ϫ5.0 mm 3 . Note that for this particular case, the uncertainty at D max per beam approximately coincided with the uncertainty at D max for the treatment plan.
To simulate systematic errors, each dose point was scaled by the magnitude of the systematic error. Such an error would occur if, for example, the machine output changed. Such a global scaling to simulate systematic errors between the true dose and that calculated with conventional dose algorithms is a crude approximation, however, is included here for comparison purposes. Systematic errors of magnitude 0%, Ϯ0.5%, Ϯ1%, Ϯ2%, Ϯ4%, Ϯ8%, and Ϯ16% were applied to the reference plan.
For each plan at each statistical uncertainty level and systematic error level, target and critical structure DVHs were obtained.
Biological indices were calculated from the DVHs. The TCP was calculated using
with a ␥ 50 value ͑the percent increase in TCP per percent increase in dose at TCPϭ50%͒ of 1.0 for a primary lung tumor. 4 The dose yielding 50% TCP (D 50 ) of 58 Gy was calculated from the information given in Munzenrider et al. 4 that for a primary lung tumor the TCPϭ70% at 70 Gy with a ␥ 50 of 1.0. The equivalent uniform dose ͑EUD͒ was calculated from
V is the volume composed of elements i , and SF 2 , the surviving fraction of cells after irradiation of 2 Gy, was set to 0.5. Equation ͑2͒ can be derived from Niemierko. 5 It is possible that due to uncertainties in dose calculation and treatment delivery that the ␥ 50 value is greater than 1, so calculations for ␥ 50 ϭ3 were also performed. The dose for the reference plan was set to give a TCP of 50% for a calculation with no uncertainty. A TCP of 50% for this plan corresponds to a maximum dose of 62.6 Gy.
The NTCP for pneumonitis in the lung was calculated using the Lyman model. 6 The volume dependence parameter ͑n͒ was 0.87, the slope of the complication probability versus the dose parameter ͑m͒ was 0.18, and the dose to the whole organ that would lead to a complication probability of 50%͑TD 50 ͒ was 24.5 Gy. These values were tabulated in Burman et al., 7 based on data taken from Emami et al.
C. ''Worst case'' TCP calculations
Only a lung plan has been studied thus far. For generality, we calculated TCP values for a variety of situations including those likely to be at the extremes of clinical reality. Due to the sigmoidal nature of the dose/response curve, TCP calculations are most strongly influenced by the lowest dose values in the volume. Hence, a step function DVH, where all the values are the ''lowest'' in the volume, represents the shape most susceptible to statistical uncertainty in dose. A parametric study was performed, where TCP for a step function DVH was calculated. Both D max ͑from 0.9 to 1.4 D 50 ͒, and the statistical uncertainty at D max ͑from 0% to 16%͒, were varied, for ␥ 50 values of 1, 3, and 5.
III. RESULTS
A. Determining the characteristics of Monte Carlo uncertainty
Figures 1͑a͒ and 1͑b͒ show the variance versus absolute dose ͑cGy/monitor unit͒ for a 10ϫ10 cm 2 open, and a 20 ϫ20 cm 2 45°wedged, 6 MV field at 100 cm SSD, respectively. This figure shows that almost all of the variance points fall along a line proportional to the dose. The variance is relatively lower in the dose buildup region ͓see the points near the ''buildup'' label in Fig. 1͑a͔͒ than in other voxels with the same dose. This reduction is because there are more primary photon interactions at the surface than elsewhere in the beam ͑especially of the low-energy components of the incident energy spectrum͒, and contaminant electrons in the beam interact at the surface. Variance is also relatively lower outside the beam ͓points left of the vertical line near the ''outside field'' label in Fig. 1͑a͔͒ and in the penumbra region ͓see the points near ''penumbra'' label in Fig. 1͑a͔͒ due to the lower average energy transfer per interaction for scattered photons as opposed to primary photons. Therefore, when using the variance/dose proportionality approximation to simulate Monte Carlo statistical uncertainty, the variance in the buildup region, in the penumbra and outside the field will be slightly overpredicted. For all Monte Carlo calculations performed in both homogeneous and heterogeneous phantoms, the correlation coefficient was greater than 0.9, indicating that the variance/dose proportionality assumption is a reliable description of the actual relation between dose and variance. Interestingly, for Monte Carlo calculations in heterogeneous geometries, lines of different slopes corresponding to voxels of different density were observed.
The generality of the variance/dose proportionality approximation is shown in the comparison of Figs. 1͑a͒ and 1͑b͒, which display the same constant of proportionality ͑slope͒, even though the beam in Fig. 1͑b͒ has been modified by a wedge.
FIG. 2. Monte
Carlo ͑left͒ and simulated ͑right͒ dose distributions for statistical uncertainty levels of ͑a͒ 14%, ͑b͒ 4%, and ͑c͒ 0.6%. The outermost isodose line corresponds to 10 cGy ͑for a 100 cGy prescription͒ and the isodose levels increase by 10 cGy. To check the implementation of the uncertainty modeling, dose calculations for a 10ϫ10 cm 2 6 MV field were calculated using Monte Carlo for three different uncertainty levels at D max , 14%, 4%, and 0.6% were performed. These same levels were simulated using the variance/dose proportionality approximation. The results of the Monte Carlo simulations and variance/dose proportionality approximation are shown in Fig. 2 . This figure shows that for the cases studied, the uncertainty appears to have been correctly applied, is valid for a range of uncertainties, and therefore, along with the results from Fig. 1 , can be used to determine the statistical uncertainty level acceptable for radiotherapy plan evaluation.
B. Determining the statistical uncertainty level acceptable for radiotherapy plan evaluation
Treatment plans are generally assessed in three ways: evaluating isodose lines plotted on a CT dataset, evaluating the DVHs for the target and critical organs, and/or evaluating predicted biological outcomes of the proposed plan. The effect of uncertainty on these three assessment criteria is discussed below. Figure 3͑a͒ shows a transverse slice of the plan calculated using collapsed cone convolution that we use as the reference plan. Figures 3͑b͒-3͑e͒ show plans with simulated Monte Carlo uncertainty levels at D max of 1%, 2%, 4%, and FIG. 3. Simulated isodose distributions for uncertainty levels in each beam at D max of ͑a͒ 0% ͑pure collapsed cone convolution calculation͒, ͑b͒ 1.0%, ͑c͒ 2.0%, ͑d͒ 4%, and ͑e͒ 16%. 16%, respectively. Obviously, increasing the uncertainty level increases the jaggedness of the isodose lines, and the ability to evaluate the plan is degraded. Although the acceptable uncertainty level for a visual plan is individual and subjective, up to a 2% level of uncertainty ͓cf. Fig. 3͑c͔͒ at D max does not significantly affect the isodose lines.
The target DVHs for uncertainty levels of 0%, 2%, 4%, 8%, and 16% are shown in Fig. 4 . Adding statistical uncertainty to a DVH has the effect of smoothing the curve ͑for a step function DVH adding statistical uncertainty is equivalent to a convolution with a Gaussian curve͒. From this graph it can be seen that a Monte Carlo uncertainty level of 2% or less does not significantly affect the DVH. Figure 5 shows lung DVHs for 0%, 8%, and 16% uncertainties. Comparing Figs. 4 and 5 shows that the effect of statistical uncertainty on a critical structure is much less than that of the target. This difference is because the effect of dose distribution uncertainty on a DVH is essentially the same as convolving the DVH with a Gaussian distribution. Hence, for a target DVH, which resembles a step function, the uncertainty has the greatest effect. However, for critical structure DVH curves, the slopes are generally shallow, and the convolution with a Gaussian has little effect.
Unlike isodose plans, in which the evaluation of the acceptance level of the statistical uncertainty is subjective, the effect of uncertainty on DVHs can be quantified by calculating biological indices. The TCP and NTCP biological indices for the different uncertainty levels are displayed in Table I  and Table II , respectively. In Table 1͑a͒ , TCP calculations are given for different error levels ͑both random and systematic͒ for 50% TCP at D max ϭ0 and ␥ 50 ϭ1. Table 1͑b͒ gives results of calculations with ␥ 50 ϭ3. Table I shows the relative insensitivity of the TCP to random errors for these ␥ 50 values, with the calculation result not changing ͑to 2 significant figures͒ for a random error level of 2% or less. However, it is seen that any systematic errors have a direct effect on the predicted TCP. Note that if random errors are present, the TCP calculation will generally underpredict the ''error-free'' value. Table II gives the predicted lung NTCP for various uncertainty levels, both random and systematic. As can be inferred from the DVHs, the random error level has little effect on the NTCP calculations. Systematic errors show more difference in the calculated NTCP values than random errors. 
V. CONCLUSIONS
The characteristics of Monte Carlo dose uncertainty as a function of the dose level have been studied. The results indicate that the variance can be approximated as being proportional to the dose to simulate statistical uncertainty in Monte Carlo dose calculations. The application of random errors to dose distributions to simulate Monte Carlo uncertainties is significantly less time consuming than actual Monte Carlo simulations.
The variance/dose proportionality approximation to simulate Monte Carlo generated statistical uncertainty was applied to a five-field treatment plan for a lung tumor. The effect of uncertainty on three radiotherapy plan evaluation criteria has been studied. Statistical uncertainty is most evident in isodose distributions, while DVHs are less sensitive. TCP and NTCP calculations are even more resistant to uncertainty than DVHs. Though the acceptable level of uncertainty varies depending on the plan evaluation criteria, it is the opinion of the authors that a statistical uncertainty of 2% or less at D max does not significantly affect the results of any of the plan evaluation criteria.
The sensitivity of TCP/NTCP calculations to systematic errors highlights the importance of using accurate dose calculation algorithms, both to simulate the transport of the radiation in patients, and also the description of the radiation source incident on the patient. The measurements used in the commissioning of the dose calculation algorithm must also be as true as possible.
